The neutrophil-to-lymphocyte ratio effectively integrates into a novel prognostic model for castration-resistant prostate cancer according to the study by Templeton et al. Systemic inflammation may provide novel insight into the pathophysiology of the disease as well as new targets for therapy and useful surrogates to optimize clinical management.
Cancer-related inflammation: An emerging prognostic domain in metastatic castration-resistant prostate carcinoma
Pinato D. J.
2014-01-01
Abstract
The neutrophil-to-lymphocyte ratio effectively integrates into a novel prognostic model for castration-resistant prostate cancer according to the study by Templeton et al. Systemic inflammation may provide novel insight into the pathophysiology of the disease as well as new targets for therapy and useful surrogates to optimize clinical management.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
